TRICAV-I
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
- Public sites
- 34
- Start date
- Jul 23, 2024
Hackensack University Medical Center provides valve care through a multidisciplinary structural heart program of cardiologists, interventional specialists and cardiac surgeons. Treatment options include TAVR, transcatheter mitral and tricuspid edge-to-edge repair, balloon valvuloplasty, minimally invasive and robotic valve repair or replacement, and open valve surgery.
This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
PARADIGM: Amplatzer Valvular Plug for PVL Closure
Englewood, NJ
Paramus, NJ
Paterson, NJ